IMF Videos Search Content For Care Partner (351) Patient (347) Healthcare Provider (213) Healthcare Professional (210) Series - Any - About the IMF (2) ASCO/EHA (71) ASH (102) Ask Dr. Durie (149) Black Swan Research Initiative (7) Community Workshops (5) Emerging Therapies (18) Facebook Live (21) Health Equity (14) IMF History (3) IMWG (12) Inspirational (15) Living Well with Myeloma (33) Myeloma in a Minute (22) Myeloma Made Simple (15) Myeloma University (12) NLB Webcasts (1) Patient & Family Webinar (11) Q&A (21) Recent News and Developments (5) Treatments (3) Trending Searches in Myeloma (4) Topics Clinical Trials (185) Financial Considerations (15) Frontline Therapy (83) Health Equity (34) Inspirational Stories (23) Insurance (6) Lab & Imaging Tests (69) Lifestyle (47) Mental & Emotional Health (28) Myeloma 101 (56) Myeloma in the News (7) Public Policy & Advocacy (17) Q&A's (42) Recorded Seminars & Workshops (15) Recorded Webinars (24) Relapse/Refractory Myeloma (136) Research Updates (193) Symptom Management (114) Myeloma Stage Early Relapse (1–3 Lines of Therapy) (147) High-Risk Myeloma (96) High-risk Smoldering Myeloma (70) Late Relapse (4–6 Lines of Therapy) (158) MGUS (85) Newly Diagnosed (Pre-Treatment or First Treatment) (158) Smoldering Myeloma (109) Types of Therapy Immunomodulatory drugs (IMiDs) (94) Immunotherapies (CAR T; BiTE, etc.) (161) Monoclonal antibodies (78) Proteasome inhibitors (66) Stem cell transplant (84) Steroids (63) Supportive Care (152) Year Published 2026 (44) 2025 (107) 2024 (93) 2023 (92) 2022 (36) 2021 (31) 2020 (13) 2019 (36) 2018 (21) 2017 (30) 2016 (24) 2015 (30) Trusted Voices Dr. Brian GM Durie (144) Dr. Joseph Mikhael (103) Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO (29) Dr. María-Victoria Mateos (7) Donna Catamero, ANP-BC, OCN, CCRC (5) Dr. Saad Usmani (4) Dr. Sigurður Kristinsson (4) Dr. Urvi A. Shah (4) Dr. Shaji Kumar (3) Dr. S. Vincent Rajkumar (1) Dr. Sagar Lonial (1) Dr. Tom Martin (1) Heather Cooper Ortner (1) Sort Newest firstOldest firstA -> ZZ -> ARelevance Increased Levels of Circulating Plasma Cells in Patients with Newly Diagnosed Multiple Myeloma Are Independently Associated with Poor Prognosis February 7, 2023 ASH Real World Efficacy and Toxicity of Selinexor: Importance of Dose Intensity and Post Progression Outcomes February 6, 2023 ASH Tocilizumab pre-treatment reduced cytokine release syndrome in relapsed/refractory multiple myeloma patients receiving cevostamab February 3, 2023 ASH Fixed Duration Therapy with Dara-KRd for High Risk Smoldering Multiple Myeloma: ASCENT Trial February 3, 2023 ASH Alnuctamab, a BCMA x CD3 T-Cell Engager, in Patients with Relapsed/Refractory Multiple Myeloma February 2, 2023 ASH Multiple Myeloma Abstracts Dealing with Health Disparities Presented at ASH 2022 February 1, 2023 ASH Monoclonal Gammopathy of Undetermined Significance (MGUS) with Multiple Paraproteins: Results from iStopMM February 1, 2023 ASH Clinical Activity of BMS-986393, a CAR T cell therapy directed at GPRC5D, in Pts with RRMM February 1, 2023 ASH Efficacy and Safety of Elranatamab in Patients with Relapsed/Refractory Multiple Myeloma: MagnetisMM-3 January 30, 2023 ASH Elranatamab Induces Durable Responses for Patients with Relapsed or Refractory Multiple Myeloma January 28, 2023 ASH Multiple Myeloma Transplant: Examining the Intersection of Access, Age and Race January 27, 2023 ASH Is there a new highly sensitive blood test to detect minimal residual disease? January 26, 2023 Ask Dr. Durie Load More